Interactions of IGF-1 with the Blood-Brain Barrier in vivo and in situ

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Neuroendocrinology

• Publication date

  2000-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000054584PMID 11025411
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potential utility of rhIGF-1 in neuromuscular and/or degenerative disease.

  2007cited by this paper
• The effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate in different regions following hypoxic-ischemic brain injury in adult rats.

  1999cited by this paper
• Saturable entry of ciliary neurotrophic factor into brain.

  1999cited by this paper
• Penetration of neurotrophins and cytokines across the blood-brain/blood-spinal cord barrier.

  1999cited by this paper
• Hepatic production and intestinal uptake of IGF-I: response to infection.

  1998cited by this paper
• Chronic Relapsing Experimental Autoimmune Encephalomyelitis: Effects of Insulin‐like Growth Factor‐I Treatment on Clinical Deficits, Lesion Severity, Glial Responses, and Blood Brain Barrier Defects

  1998cited by this paper
• Induction of IGF-1 mRNA expression following traumatic injury to the postnatal brain.

  1998cited by this paper
• Regulation of experimental autoimmune encephalomyelitis with insulin-like growth factor (IGF-1) and IGF-1/IGF-binding protein-3 complex (IGF-1/IGFBP3).

  1998cited by this paper
• Permeability of the blood-brain barrier to neurotrophins.

  1998cited by this paper
• Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group.

  1997cited by this paper
• Blood-brain barrier permeability to ebiratide and TNF in acute spinal cord injury.

  1997cited by this paper
• Rediscovering an old friend, IGF-I: potential use in the treatment of neurodegenerative diseases.

  1997cited by this paper
• Effect of recombinant human insulin-like growth factor-I on progression of ALS

  1997cited by this paper
• Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF.

  1996cited by this paper
• Passage of peptides across the blood-brain barrier: pathophysiological perspectives.

  1996cited by this paper
• Insulin-like growth factor I treatment reduces clinical deficits and lesion severity in acute demyelinating experimental autoimmune encephalomyelitis

  1995cited by this paper
• Opposite direction of transport across the blood-brain barrier for Tyr-MIF-1 and MIF-1: comparison with morphine.

  1994cited by this paper
• Insulin-like growth factor binding proteins in the human circulation: a review.

  1994cited by this paper
• Insulin-like growth factors cross the blood-brain barrier.

  1994cited by this paper
• Insulin-like growth factor-I: potential for treatment of motor neuronal disorders.

  1993cited by this paper
• Bioavailability of insulin-like growth factors (IGFs) in rats determined by the molecular distribution of human IGF-binding protein-3.

  1993cited by this paper
• Distribution of circulating insulin-like growth factor-I (IGF-I) into tissues.

  1991cited by this paper
• Enhanced potency of truncated insulin-like growth factor-I (des(1-3)IGF-I) relative to IGF-I in lit/lit mice.

  1990cited by this paper
• Human blood-brain barrier insulin-like growth factor receptor.

  1988cited by this paper
• Demonstration and structural comparison of receptors for insulin-like growth factor-I and -II (IGF-I and -II) in brain and blood-brain barrier.

  1987cited by this paper
• Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data

  1983cited by this paper

• Hippocampal Neurogenesis via Light-Intensity Running and Its Mechanism.

  2025cites this paper
• Тhe role of neurotrophic factors during rehabilitation therapy in patients with cerebral palsy

  2025cites this paper
• The Possible Role of Postnatal Biphasic Dysregulation of IGF-1 Tone in the Etiology of Idiopathic Autism Spectrum Disorder

  2025cites this paper
• Insulin- Like Growth Factor-1 as Brain-Body Connector.

  2025cites this paper
• Exercise, Neuroprotective Exerkines, and Parkinson’s Disease: A Narrative Review

  2024cites this paper
• Insulin-like growth factor-1 and cognitive health: Exploring cellular, preclinical, and clinical dimensions.

  2024cites this paper
• White matter protection with insulin-like growth factor-1 after hypoxia-ischaemia in preterm foetal sheep

  2024cites this paper
• The IGF System and Aging

  2024cites this paper
• IGF-1 infusion increases growth in fetal sheep when euinsulinemia is maintained.

  2024cites this paper
• Targeting the Multiple Complex Processes of Hypoxia-Ischemia to Achieve Neuroprotection

  2024cites this paper
• PEAK Mood, Mind, and Marks: a pilot study of an intervention to support university students’ mental and cognitive health through physical exercise

  2024cites this paper
• Effect of ultrasound-mediated blood-spinal cord barrier opening on survival and motor function in females in an amyotrophic lateral sclerosis mouse model

  2024cites this paper
• Insulin and the blood-brain barrier.

  2024cites this paper
• Palmitic Acid Modulation of the Insulin-Like Growth Factor System in Hypothalamic Astrocytes and Neurons

  2024cites this paper
• Insulin-Like Growth Factor Signaling in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies

  2024cites this paper
• Choroid plexus extracellular vesicle transport of blood-borne insulin-like growth factor 1 to the hippocampus of the immature brain

  2024cites this paper
• Molecular mechanisms underlying physical exercise-induced brain BDNF overproduction

  2023cites this paper
• Application of In vitro transcytosis models to brain targeted biologics

  2023cites this paper
• Insulin‐like growth factor‐2 is a promising candidate for the treatment and prevention of Alzheimer's disease

  2023cites this paper
• Diabetic vascular diseases: molecular mechanisms and therapeutic strategies

  2023cites this paper
• Modulation of neurotrophic factors in the treatment of dementia, stroke and TBI: Effects of Cerebrolysin

  2023cites this paper
• Insulin-like growth factor 1 supplementation supports motor coordination and affects myelination in preterm pigs

  2023cites this paper
• Phenotype-structured model of intra-clonal heterogeneity and drug resistance in multiple myeloma.

  2023cites this paper
• Perioperative growth hormone levels as an early predictor of new-onset secondary adrenal insufficiency following transsphenoidal pituitary tumor resection.

  2023cites this paper
• The metabolic effects of resumption of a high fat diet after weight loss are sex dependent in mice

  2023cites this paper
• Characterization of choroid plexus in the preterm rabbit pup following subcutaneous administration of recombinant human IGF-1/IGFBP-3

  2023cites this paper
• Growth Hormone Increases BDNF and mTOR Expression in Specific Brain Regions after Photothrombotic Stroke in Mice

  2022cites this paper
• Epitope mapping of a blood-brain barrier crossing antibody targeting the cysteine-rich region of IGF1R using hydrogen-exchange mass spectrometry enabled by electrochemical reduction.

  2022cites this paper
• Beyond Appetite: Acylated Ghrelin As A Learning, Memory and Fear Behavior-modulating Hormone.

  2022cites this paper
• Evidence for an alternative insulin transporter at the blood-brain barrier.

  2022cites this paper
• Research Progress on Neuroprotection of Insulin-like Growth Factor-1 towards Glutamate-Induced Neurotoxicity

  2022influential citation
• Age-related decline in circulating IGF-1 associates with impaired neurovascular coupling responses in older adults

  2022cites this paper
• Association between the serum insulin‐like growth factor‐1 concentration in the first trimester of pregnancy and postpartum depression

  2021cites this paper
• Preclinical and clinical evidence of IGF-1 as a prognostic marker and acute intervention with ischemic stroke

  2021cites this paper
• How alcohol affects insulin‐like growth factor‐1's influences on the onset of puberty: A critical review

  2021cites this paper
• Neurotrophic Therapy for ALS/MND

  2021cites this paper
• Glucose signaling in the brain and periphery to memory.

  2020cites this paper
• Compromised IGF signaling causes caspase-6 activation in Huntington disease.

  2020cites this paper
• Effects of adipokine administration to the hypothalamic preoptic area on body temperature in rats.

  2020cites this paper
• LC-MS/MS analysis of partial structure of Panax ginseng protein and its distribution in vivo.

  2020cites this paper
• Combined Treatment with Insulin-Like Growth Factor 1 and AMD3100 Improves Motor Outcome in a Murine Model of Neonatal Hypoxic-Ischemic Encephalopathy

  2020cites this paper
• Peripheral Circulation and Astrocytes Contribute to the MSC-Mediated Increase in IGF-1 Levels in the Infarct Cortex in a dMCAO Rat Model

  2020cites this paper
• Ionizing radiation-induced risks to the central nervous system and countermeasures in cellular and rodent models

  2020cites this paper
• Impact of Long-Term HFD Intake on the Peripheral and Central IGF System in Male and Female Mice

  2020cites this paper
• The impact of trophic and immunomodulatory factors on oligodendrocyte maturation: Potential treatments for encephalopathy of prematurity

  2020cites this paper
• Insulin‐Like Growth Factor and Insulin‐Like Growth Factor Receptor Expression in Human Idiopathic Autism Fusiform Gyrus Tissue

  2020cites this paper
• Insulin-Like Growth Factor 1 Increases GABAergic Neurotransmission to GnRH Neurons via Suppressing the Retrograde Tonic Endocannabinoid Signaling Pathway in Mice

  2020cites this paper
• Neurobiological effects of aerobic exercise, with a focus on patients with schizophrenia

  2019cites this paper
• Growth Hormone Deficiency Following Traumatic Brain Injury

  2019cites this paper
• Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression

  2018cites this paper
• Insulin-like Growth Factor 1 (IGF-1) as a marker of cognitive decline in normal ageing: A review.

  2018cites this paper
• Hormones of energy homeostasis : linking weight loss and cognition in Parkinson's disease?

  2018cites this paper
• The Neuroprotective Effects of Exercise: Maintaining a Healthy Brain Throughout Aging

  2018cites this paper
• On the Run for Hippocampal Plasticity.

  2018cites this paper
• Pregnancy-Associated Plasma Protein-aa Regulates Photoreceptor Synaptic Development to Mediate Visually Guided Behavior

  2018cites this paper
• Efficient expression of stable recombinant human insulin-like growth factor-1 fusion with human serum albumin in Chinese hamster ovary cells

  2017cites this paper
• Biological hypotheses and biomarkers of bipolar disorder

  2017influential citation
• The role of the growth hormone/insulin-like growth factor-1 axis in neuromuscular degeneration in a mouse model of amyotrophic lateral sclerosis

  2017cites this paper
• Growth hormone in the brain

  2017cites this paper
• Central IGF‐I Receptors in the Brain are Instrumental to Neuroprotection by Systemically Injected IGF‐I in a Rat Model for Ischemic Stroke

  2016cites this paper
• The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders.

  2016cites this paper
• Neurogenic Effects of Cell-Free Extracts of Adipose Stem Cells

  2016cites this paper
• IGF-1 protects dopamine neurons against oxidative stress: association with changes in phosphokinases

  2016cites this paper
• Spinal Cord Injury Changes Cytokine Transport.

  2016cites this paper
• Insulin Like Growth Factor (IGF)

  2016cites this paper
• Reply to: Improving Research Standards to Restore Trust in Intranasal Oxytocin.

  2016cites this paper
• Plasma insulin-like growth factor I levels are higher in depressive and anxiety disorders, but lower in antidepressant medication users.

  2016cites this paper
• Involvement of the Blood-Brain Barrier in Metabolic Regulation.

  2016cites this paper
• Supplementation of fermented yeast culture augments the growth and reduces the age at puberty in male Murrah buffalo calves

  2016cites this paper
• A 20-week program of resistance or concurrent exercise improves symptoms of schizophrenia: results of a blind, randomized controlled trial.

  2015cites this paper
• The role of neuronal insulin/insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer's disease: possible therapeutic implications.

  2014cites this paper
• Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer’s disease: an observational study

  2014cites this paper
• Engrailed2 modulates cerebellar granule neuron precursor proliferation, differentiation and insulin-like growth factor 1 signaling during postnatal development

  2014cites this paper
• Relationship between concentrations of IGF-1 and IGFBP-3 and preoperative depression risk, and effect of psychological intervention on outcomes of high-grade glioma patients with preoperative depression in a 2-year prospective study

  2014cites this paper
• IGF‐1 Alleviates NMDA‐Induced Excitotoxicity in Cultured Hippocampal Neurons Against Autophagy via the NR2B/PI3K‐AKT‐mTOR Pathway

  2014cites this paper
• Neurotrophic Factors and Ethanol Neurotoxicity

  2014cites this paper
• Interaction between serum BDNF and aerobic fitness predicts recognition memory in healthy young adults.

  2014cites this paper
• The Neuroprotective Effects of Intramuscular Insulin-Like Growth Factor-I Treatment in Brain Ischemic Rats

  2013cites this paper
• Insulin‐like growth factor‐1 secreted by brain microvascular endothelial cells attenuates neuron injury upon ischemia

  2013cites this paper
• Growth Hormone and Anabolic Androgenic Steroids : Effects on Neurochemistry and Cognition

  2013cites this paper
• Major Depressive Disorder and Biomarkers

  2013cites this paper
• Growth hormone and cognitive function

  2013cites this paper
• Estrogens need insulin-like growth factor I cooperation to exert their neuroprotective effects in post-menopausal women

  2013cites this paper
• Epigenetic regulation of BDNF-TrkB signaling in the pathophysiology and treatment of mood disorders

  2013cites this paper
• Saturable Leptin Transport Across the BBB Persists in EAE Mice

  2013cites this paper
• Effects of intracerebroventricular application of insulin-like growth factor 1 and its N-terminal tripeptide on cerebral recovery following cardiac arrest in rats.

  2013cites this paper
• Chapter 230 – Neurotrophic Peptides

  2013cites this paper
• Stroke Neuroprotection: Oestrogen and Insulin‐Like Growth Factor‐1 Interactions and the Role of Microglia

  2013cites this paper
• Insulin-Like Growth Factor-1 Inhibits 6-Hydroxydopamine-Mediated Endoplasmic Reticulum Stress-Induced Apoptosis via Regulation of Heme Oxygenase-1 and Nrf2 Expression in PC12 Cells

  2012cites this paper
• Vascular endothelial growth factor and other angioglioneurins: key molecules in brain development and restoration.

  2012cites this paper
• C-Reactive Protein Increases BBB Permeability: Implications for Obesity and Neuroinflammation

  2012cites this paper
• Design and Fabrication of a Biodegradable, Covalently Crosslinked Shape-Memory Alginate Scaffold for Cell and Growth Factor Delivery

  2012cites this paper
• Native and Complexed IGF-1: Biodistribution and Pharmacokinetics in Infantile Neuronal Ceroid Lipofuscinosis

  2012cites this paper
• Motor neuron trophic factors: therapeutic use in ALS?

  2011cites this paper
• Minimally Invasive Approach to the Repair of InjuredSkeletal Muscle with Biodegradable Scaffolds

  2011cites this paper
• Long-term deficiency of circulating and hippocampal insulin-like growth factor I induces depressive behavior in adult mice: a potential model of geriatric depression.

  2011cites this paper
• Circulating IGF1 regulates hippocampal IGF1 levels and brain gene expression during adolescence.

  2011cites this paper
• A mutation in the dynein heavy chain gene compensates for energy deficit of mutant SOD1 mice and increases potentially neuroprotective IGF-1

  2011cites this paper
• Concentrations of IGF-I and IGFBP-3 and brain tumor risk in the European Prospective Investigation into Cancer and Nutrition.

  2011cites this paper
• Peptides: important tools for the treatment of central nervous system disorders.

  2011cites this paper